» Authors » Jennifer Sipos

Jennifer Sipos

Explore the profile of Jennifer Sipos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 200
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yildiz B, Boguszewski C, Boguszewski M, Busetto L, Celik O, Fuleihan G, et al.
Hormones (Athens) . 2024 Apr; 23(2):183-204. PMID: 38619812
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11 Annual Meeting of EndoBridge included state-of-the-art lectures...
2.
Wu A, DAmico N, Healy E, Kharouta M, Khandel G, Deshane A, et al.
Tech Innov Patient Support Radiat Oncol . 2021 Nov; 20:28-34. PMID: 34765751
Background: Radiation-induced hypothyroidism is a common toxicity of head and neck radiation. Our re-planning study aimed to reduce thyroid dose while maintaining target coverage with IMRT. Methods: We retrospectively identified...
3.
Nguyen X, Job J, Fiorillo L, Sipos J
Radiol Clin North Am . 2020 Oct; 58(6):1019-1031. PMID: 33040845
Radiologists very frequently encounter incidental findings related to the thyroid gland. Given increases in imaging use over the past several decades, thyroid incidentalomas are increasingly encountered in clinical practice, and...
4.
Owen D, Konda B, Sipos J, Liu T, Webb A, Ringel M, et al.
J Natl Compr Canc Netw . 2019 May; 17(5):409-413. PMID: 31085763
BRAF V600E mutations occur in approximately 40% of all patients with papillary thyroid cancer (PTC) and are associated with a worse prognosis in population studies. Treatment with single-agent BRAF inhibitors...
5.
Hurst Z, Liyanarachchi S, He H, Brock P, Sipos J, Nabhan F, et al.
Thyroid . 2019 Jan; 29(4):530-539. PMID: 30654714
Background: Thyroid cancer patients with radioiodine-refractory (RAI-R) disease, resulting from insufficient RAI delivery and/or RAI resistance, have increased mortality and limited treatment options. To date, studies have largely focused on...
6.
Saporito D, Brock P, Hampel H, Sipos J, Fernandez S, Liyanarachchi S, et al.
Fam Cancer . 2017 Oct; 17(3):431-434. PMID: 29027612
Familial non-medullary thyroid cancer (FNMTC) is clinically defined as two or more first-degree relatives with NMTC and appears to follow an autosomal dominant inheritance pattern. Approximately 5-7% of NMTC is...
7.
Hollingsworth B, Senter L, Zhang X, Brock G, Jarjour W, Nagy R, et al.
J Clin Endocrinol Metab . 2016 Aug; 101(11):4085-4093. PMID: 27533304
Context: Sialadenitis and xerostomia are major adverse effects of I therapy in thyroid cancer patients. The risk factors for these adverse effects, other than administered activity of I, have not...
8.
Alexander E, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, et al.
J Clin Endocrinol Metab . 2013 Oct; 99(1):119-25. PMID: 24152684
Background: Increasingly, patients with thyroid nodule cytology labeled atypical (or follicular lesion) of undetermined significance (AUS/FLUS) or follicular neoplasm (FN) undergo diagnostic analysis with the Afirma gene expression classifier (GEC)....
9.
Mazzaferri E, Sipos J
Thyroid . 2008 Jun; 18(6):597-602. PMID: 18578607
Background: Decisions involving the management of patients with papillary microcarcinoma are complex. Here we review and consider the literature in this area including two studies published in this issue of...
10.
Rosen C, Ackert-Bicknell C, Adamo M, Shultz K, Rubin J, Donahue L, et al.
Bone . 2004 Nov; 35(5):1046-58. PMID: 15542029
Targeted gene studies have demonstrated the importance of insulin-like growth factor-I (IGF-I) for osteoblast (OB) differentiation and the acquisition of peak bone mineral density (BMD). The skeletal response to allelic...